Reporting to the Vice President and Head of the Rare Emergency Medicine Business Unit, this role is responsible for developing and executing the national sales strategy, leading a high-performing team of Regional Business Directors, and translating business unit priorities into consistent execution across key customer segments, including hospitals, health systems, integrated delivery networks, emergency medicine, critical care, and specialty provider settings. As the commercial steward of the REM field organization, this role is accountable for sales force effectiveness, forecasting, organizational capability, launch readiness, and the successful commercialization of both established brands and future growth opportunities, including Bentracimab.